Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Prep: Cook: Serves:

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Share this story

Comments

‘A Cell’s Life’: the comic strip demystifying Parkinson’s research

Web comic book series explains Parkinson's stem cell treatments

Poem for World Parkinson’s Day: “Parkinson’s can be a state of mind, rather than an illness”

Daily Parkinson’s poet pens new piece for World Parkinson’s Day

“People are capable of so much more than they think”

We talk to Dr Modugno about the centre he directs in Italy

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”

Could a prostate drug lower the risk of Parkinson’s disease?

Researchers in the US, Denmark and China have found that a type of medication used to treat enlarged prostate, known as alpha-blockers, is associated with a lower risk of Parkinson’s disease. As part of the study, the research team analysed patient data from 150,000 men using medications like the alpha-blocker terazosin – which has previously been shown to slow Parkinson’s disease progression in animals – and compared their findings to data from 150,000 men using the alpha-blocker tamsulosin. They found that men taking terazosin were 12 to 37% less likely to develop Parkinson’s disease. Jacob Simmering, corresponding author of the study, said: “Despite the relative differences in population and health care system structure, we found a similar protective effect in both [the US and Denmark]. “If these results are confirmed through further investigation, especially a randomised clinical trial, terazosin may provide neuroprotection and potentially prevent – and not just manage…

People with Parkinson’s disease have a “high interest” in herbal drugs, study finds

Researchers in Germany conducted a survey to assess how people with Parkinson’s disease perceive and experience medical cannabis. As part of the study, the team analysed answers from more than 1,300 people with Parkinson’s. They found that 65% of participants who did not use medical cannabis were interested in it, but lacked knowledge and feared side effects. Around 8% of participants reported using cannabis; of these, 54% reported beneficial effects – including 40% who reported reduced pain. Professor Dr Carsten Buhmann, lead study investigator, said: “Our data confirm that Parkinson’s disease patients have a high interest in treatment with medicinal cannabis […]. The data reported here may help physicians decide which patients could benefit, which symptoms could be addressed, and which type of cannabinoid and route of administration might be suitable. “It has to be stressed, though, that our findings are based on subjective patient reports and that clinically appropriate…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Resources & Tools

‘A Cell’s Life’: the comic strip demystifying Parkinson’s research

Perspectives

Poem for World Parkinson’s Day: “Parkinson’s can be a state of mind, rather than an illness”

Interviews

“People are capable of so much more than they think”

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

People with Parkinson’s disease have a “high interest” in herbal drugs, study finds

{title}

Subscribe

Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Resources & Tools

‘A Cell’s Life’: the comic strip demystifying Parkinson’s research

Perspectives

Poem for World Parkinson’s Day: “Parkinson’s can be a state of mind, rather than an illness”

Interviews

“People are capable of so much more than they think”

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

People with Parkinson’s disease have a “high interest” in herbal drugs, study finds

{title}

Subscribe

Sign in